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Adult hematopoietic stem cells (HSCs) are main-
tained in specialized niches within the bone marrow
under steady-state conditions andmobilize for extra-
medullary hematopoiesis during periods of stress
such as bacterial infections. However, the underlying
mechanisms are unclear. We show that systemic
infection of mice with Escherichia coli, commonly
associated with bacteremia in humans, mobilizes
functional HSCs to the spleen. Accumulation of
splenic HSCs (CD150+CD48-Lin/lowSca1+cKit+)
was diminished in TLR4-deficient and RIPK2-defi-
cient mice, implicating TLRs and cytosolic NOD1/
NOD2 signaling in the process. Accordingly, dual
stimulation of NOD1 and TLR4 in radio-resistant cells
alone was sufficient to mobilize HSCs, while TLR4
expression on HSCs was dispensable. Mechanisti-
cally, TLR4 and NOD1 synergistically induced granu-
locyte colony-stimulating factor (G-CSF), which was
required for extramedullary HSC accumulation.
Mobilized HSCs and progenitor cells gave rise to
neutrophils and monocytes and contributed to
limiting secondary infection.
INTRODUCTION
Hematopoietic stem cells (HSCs) are defined by their ability to
give rise to all cells of the blood system and to self-renew, where
cell division results in at least one daughter that retains the full
developmental potential of its parent. The majority of HSCs
reside in the bone marrow where they are surrounded by a
network of supporting cells, collectively termed the stem cell
niche, while a smaller subset of HSCs reside in the spleen, which
serves as a site for hematopoiesis during embryogenesis
and periods of duress (Morrison and Spradling, 2008). While
residency in a niche is essential for HSC maintenance, HSCs
regularly traffic through the blood stream in a process that mayCell Hfacilitate competition for niches to ensure a robust pool of
stem cells (Wright et al., 2001). Moreover, HSCs have been iso-
lated from lymphatic ducts, indicating that HSCs travel through
peripheral tissues and have the potential to provide a local
source of cell production (Massberg et al., 2007). While much
is known about HSC activity under homeostatic conditions,
how HSCs function during periods of stress is less clear.
Bacterial infection is a common form of stress that can induce
profound effects on the fate of hematopoietic stem and pro-
genitor cells (HSPCs). Host-derived pattern recognition recep-
tors (PRRs) sense components of bacteria and respond by
activating proinflammatory signaling pathways that aid in the
defense against infection. Escherichia coli is a Gram-negative
bacterium that normally resides in the intestine, but is also a
major cause of sepsis in hospitalized patients (Laupland,
2013). The cell wall of E. coli contains lipopolysaccharide
(LPS), which is sensed by Toll-like receptor 4 (TLR4), and
peptidoglycan, whose cleavage products are sensed by the
nucleotide-binding oligomerization domain containing (NOD)-
like-receptors (NLRs) NOD1 and NOD2. TLR4 signals via the
adaptor proteins myeloid differentiation primary response 88
(Myd88) and TIR-domain-containing adaptor inducing inter-
ferons (TRIF), while NOD1 and NOD2 signaling requires the
adaptor protein receptor-interacting serine-threonine kinase 2
(RIPK2), which leads to the activation of NF-kB and MAPK path-
ways (Franchi et al., 2009; Sartor, 2008).
TLR4 and TLR2 are expressed on the surface of Lineage/low
Sca1+ cKit+ (LSK) cells, which mark both HSCs and non-self-
renewing progenitors, suggesting that HSPCs may actively
participate in innate immune responses (Nagai et al., 2006). Acti-
vation of TLRs has been proposed to alter the fate and function
of HSCs either by direct intracellular signaling, or indirectly via
production of inflammatory cytokines or alterations in the bone
marrow niche (Baldridge et al., 2010; Chen et al., 2010; Esplin
et al., 2011; Essers et al., 2009; Johns et al., 2009; Rodriguez
et al., 2009; Scumpia et al., 2010; Takizawa et al., 2011). To
date, only one study has tested the function of HSCs following
live bacterial infection (Baldridge et al., 2010). However, HSC
activity was not assessed in unfractionated bone marrow or in
sites of extramedullary hematopoiesis such as the spleen, and
the surfacemarker profile of functional HSCs during infection stillost & Microbe 15, 779–791, June 11, 2014 ª2014 Elsevier Inc. 779
Figure 1. Infection Reduces HSC Activity in Bone Marrow and Increases HSC Activity in Spleen
(A–D) WT mice were injected with 13 108 E. coli K12 i.p. and after 6 days (A and B) 33 105 whole bone marrow (WBM) or (C and D) 13 106 splenocytes were
mixed with 3 3 105 WBM and transplanted into lethally irradiated recipients. Peripheral blood chimerism of myeloid (Mac1+), B-lineage (B220+), and T-lineage
(CD3+) cells was analyzed by flow cytometry every 4 weeks.
(A and C) n = 12 mice per condition from two experiments. *p < 0.05 by t test.
(B and D) n = 9–10mice per condition from two experiments. *p < 0.05 **p < 0.05 by two-way ANOVA versus recipients of PBS cells at each time point. Error bars
represent SEM.
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bacterial infection alters the phenotype and function of HSCs
in the bone marrow and spleen. Furthermore, it remains to be
determined whether HSCs directly sense and respond to com-
ponents of bacteria or whether infection merely alters the bone
marrow microenvironment and modulates their fate indirectly.
Activation of TLRs can also affect the localization of HSPCs.
Systemic administration of LPS results in the accumulation of
HSPCs in the spleen (Esplin et al., 2011; Vos et al., 1972), but
the signals and cell types responsible for this phenomenon are
unknown. Repeated administration of granulocyte colony-
stimulating factor (G-CSF), which can be produced in response
to infection or LPS (Hareng and Hartung, 2002), induces the
mobilization of HSPCs from bone marrow to peripheral blood
and spleen and is the preferredmobilizing agent used in the clinic
(Du¨hrsen et al., 1988; Molineux et al., 1990; Morrison et al., 1997;
To et al., 2011). While the mechanisms of G-CSF-induced
mobilization are well characterized (Levesque and Winkler,
2008; Mazo et al., 2011), it is currently unclear whether the
production of endogenous G-CSF mobilizes HSCs during infec-
tion. In the current study, we investigated the mechanisms by
which bacterial infection influences the localization and function
of HSCs.
RESULTS
Systemic E. coli Infection Reduces Functional HSCs in
Bone Marrow
To understand the mechanisms underlying the regulation of
HSCs during infection, we developed a model of systemic infec-
tion using the Gram-negative bacterium Escherichia coli K12.780 Cell Host & Microbe 15, 779–791, June 11, 2014 ª2014 ElsevierThis bacteriumwas chosen because E. coli is commonly isolated
from the blood of humans suffering from bacteremia (Laupland,
2013) and because systemic administration was sublethal in
wild-type (WT) mice for all conditions tested, thus allowing an
extended window of time to assess HSC activity. To determine
whether HSC activity is altered in the bone marrow after E. coli
infection, we performed competitive transplantation experi-
ments in which WT (CD45.1) mice were treated with PBS or
E. coli, and after 6 days, 3 3 105 whole bone marrow (WBM)
was mixed with 3 3 105 untreated (CD45.2) WBM and trans-
planted into lethally irradiated (CD45.2) recipients and peripheral
blood reconstitution was followed for 16 weeks (Figures 1A
and 1B). To quantitatively compare levels of reconstitution, we
converted percent chimerism after 16 weeks into repopulating
units (RUs) (Harrison et al., 1993). In two independent experi-
ments, WBM from E. coli-infected mice had on average 2.1-
fold fewer RUs compared with PBS-treated WBM (Figure 1A).
The contribution of E. coli-infected WBM to the B cell lineage,
but not the myeloid or T cell lineage, was significantly reduced
after 16 weeks (Figure 1B). These results indicate that total
HSC activity in the bone marrow of mice infected with E. coli
for 6 days was moderately diminished compared to that of unin-
fected mice.
SystemicE. coli Infection Promotes the Accumulation of
Functional HSCs in Spleen
The spleen can serve as a site for extramedullary hematopoiesis
during periods of stress, and previous studies have found
that treatment of mice with LPS, which mimics some aspects
of infection, induces the accumulation of HSPCs in the spleen
(Esplin et al., 2011; Vos et al., 1972). To determine whetherInc.
Figure 2. The Majority of HSC Activity Exists in the CD150+ CD48– Fraction of Bone Marrow and Spleen during Infection
(A–D) WT mice were injected with 1 3 108 E. coli K12 i.p. and after 6 days (top), bone marrow or (bottom) splenocytes were sorted and resorted based on
positive or negative expression of (A and B) CD150 or (C and D) CD48.
(B and D) Positive or negative fractions from (top) bone marrow or (bottom) spleen were mixed with 3 3 105 WBM and transplanted into lethally irradiated
recipients. Peripheral blood chimerism of myeloid (Mac1+), B-lineage (B220+), and T-lineage (CD3+) cells was analyzed by flow cytometry. Connected data
points represent individual mice bled every 4 weeks. Data are from two experiments for each condition. The black line represents the background threshold of
0.3%, below which we could not detect chimerism. See also Figures S1 and S2, Table S1, and Table S2.
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we treatedWT (CD45.1) mice with PBS or E. coli and after 6 days
mixed 1 3 106 splenocytes with 3 3 105 untreated (CD45.2)
WBM and transplanted these cells into lethally irradiated
(CD45.2) recipients and followed peripheral blood reconstitution
for 16 weeks (Figures 1C and 1D). In two independent experi-
ments, splenocytes from E. coli infected mice had on average
38.9-fold more RUs than splenocytes from PBS treated mice
(Figure 1C). We defined long-term multilineage reconstitution
(LTMR) activity, characteristic of functional HSCs, as the pres-
ence of greater than 0.3% of donor-derived myeloid, T-lineage,
and B-lineage cells at 16 weeks posttransplant. Whereas
splenocytes from PBS-treated donors contributed minimally to
myeloid and lymphoid lineages over 16 weeks (2/9 LTMR),
consistent with a very small resident population of splenic
HSCs under steady-state conditions, splenocytes from E. coli
infected donors contributed robustly to myeloid and lymphoid
lineages over 16 weeks (9/9 LTMR) (Figure 1D). These results
indicate that functional HSC activity is enhanced in the spleensCell Hof mice infected with E. coli for 6 days compared with spleens
of uninfected mice.
The Majority of HSC Activity Is within the CD150+,
CD48–, Lineage–/low, cKit+, and Sca1+ Fractions of Bone
Marrow and Spleen during Infection
All functional HSC activity is present within the CD150+ CD48
Lineage/low Sca1+ cKit+ fraction of bone marrow under
steady-state conditions (Kiel et al., 2005), yet administration of
live bacteria, LPS, or inflammatory cytokines can alter the
expression of these surfacemarkers on various cell types (Howie
et al., 2002; Munitz et al., 2006; Zhang et al., 2008). Therefore we
set out to determine whether functional HSCs retain their surface
marker profile during infection. We performed competitive
reconstitution experiments where bone marrow cells or spleno-
cytes from E. coli-infectedmice were fractionated based on pos-
itive or negative expression of CD150 or CD48 (Figure 2 and see
Figure S1 available online). Donor cells were transplanted based
on the percentage of each population within infected boneost & Microbe 15, 779–791, June 11, 2014 ª2014 Elsevier Inc. 781
(legend on next page)
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mice that received CD150+ bone marrow cells (10/10 LTMR) or
splenocytes (7/7 LTMR) were long-term multilineage reconsti-
tuted, whereas nomice that received CD150 bonemarrow cells
(0/9 LTMR) or splenocytes (0/9 LTMR) were long-term multiline-
age reconstituted (Figures 2A and 2B; Table S2). Transplanted
CD150 bone marrow cells and splenocytes gave transient
myeloid reconstitution with sustained yet limited lymphoid
reconstitution, consistent with previously published data indi-
cating that CD150 bonemarrow cells contain transiently recon-
stituting multipotent progenitors (Kiel et al., 2008).
Under steady-state conditions, all LTMR activity in adult bone
marrow is contained within the CD48 negative fraction of cells
(Kiel et al., 2005). In E. coli-infected mice, while seven of ten
and nine of ten recipients of CD48 bone marrow and spleno-
cytes, respectively, were LTMR, we found that two of ten and
two of ten recipients of CD48+ bone marrow and splenocytes,
respectively, were LTMR (Figures 2C and 2D; Table S2). These
results indicate that all HSC activity is present in the CD150+
fraction and a majority is present in the CD48 fraction of bone
marrow and spleen, while a minority of HSC activity is present
in the CD48+ fraction of bone marrow and spleen 6 days after
E. coli infection.
We performed similar experiments by sorting bone marrow
cells and splenocytes from infected mice based on positive or
negative expression of Sca1, cKit, or Lineage markers (Figures
S1 and S2). We found that all HSC activity was present in the
Sca1+ and cKit+ fractions and a majority of HSC activity was
present in the Lineage/low fraction of bone marrow and spleen
during infection. A minority of HSC activity was present in the
Lineage+ fraction of the bone marrow but not the spleen
(Figure S2; Table S2). Altogether, we find that the majority of
functional HSCs are contained within the CD150+ CD48 LSK
fraction of bone marrow and spleen 6 days after infection with
E. coli.
Systemic E. coli Infection Dynamically Affects HSPCs in
Bone Marrow and Spleen
Having confirmed the surface marker profile of HSCs following
infection, we measured the frequency of HSPCs (LSK) and
HSCs (CD150+ CD48 CD41 LSK) in bone marrow and spleen
over 12 days of infection (Figures 3A and 3B). Although CD41
expression on HSCs increases with age, it is very low on HSCs
from young adult mice, and its inclusion helps to exclude
contaminating megakaryocytes (Kiel et al., 2005). E. coli infec-
tion resulted in transient bone marrow hypocellularity at days 3
and 6 that normalized by day 9 along with mild splenomegaly
that did not reach significance (Figures 3C and 3D). Total LSK
cells nonsignificantly reduced in the bone marrow by day 6
and recovered thereafter, while LSK cells in the spleen were
nonsignificantly increased by days 3 and 6 and diminished by
day 12 (Figures 3E and 3F). Total CD150+ CD48 CD41 LSK
cells were significantly reduced in the bone marrow by day 3Figure 3. Kinetics of Hematopoietic Stem and Progenitor Cells during
(A–H) WT mice were injected with 13 108 E. coli K12 i.p., and femur and tibia o
plots from (A) bone marrow or (B) spleen and quantification of (C) total BM cells, (D
LSK, (G) total BM HSCs (CD150+ CD48 CD41 LSK), and (H) total splenic HSC
one-way ANOVA. (ns), not significant. See also Figures S3 and S4.
Cell Hand recovered to near-normal levels by day 9, while CD150+
CD48 CD41 LSK cells in the spleen were significantly
increased by day 6, peaked by day 9, and began to diminish
by day 12 (Figures 3G and 3H). These results suggest that
systemic infection induces a reduction and subsequent recovery
of HSCs in bone marrow along with a delayed accumulation of
HSCs in the spleen.
To determine whether the accumulation of extramedullary
HSCs during infection was specific to the spleen or also
occurred in other tissues, we injected WT mice with either PBS
or E. coli and after 9 days harvested bone marrow, spleen, liver,
and inguinal lymph nodes and stained these tissues for markers
of HSCs (Figure S3). In contrast to the spleen, we did not observe
any CD150+ CD48 CD41 LSK cells in the liver or inguinal
lymph nodes of infected mice (Figure S3). These data suggest
that the spleen may serve as a preferential site for HSC accumu-
lation during E. coli infection.
Mobilization Is the Primary Mechanism for HSC
Accumulation in Spleen
Given that a small subset of functional HSCs exists in the spleen
under steady-state conditions (Morrison and Spradling, 2008), it
was initially unclear whether the accumulation of splenic HSCs
during infection was a result of local cell division, mobilization
of HSCs from the bonemarrow to the spleen, or both. To address
this issue, we infected mice with E. coli and after 6 days sorted
HSCs from the bone marrow or spleen and stained them for
Ki67, a marker of cycling cells (Figure S4). We found no signifi-
cant difference in the percentage of Ki67+ HSCs from uninfected
bone marrow (2.7% ± 2.0%), infected bone marrow (2.4% ±
1.4%), or infected spleen (4.0% ± 2.5%) (Figure S4). Since this
level of proliferation cannot account for the greater than 30-
fold expansion of HSCs in spleen by 6 days, the studies suggest
that mobilization is the primary mechanism underlying the accu-
mulation of splenic HSCs during E. coli infection.
Accumulation of Splenic HSCs during Infection Is
Dependent on PRRs
Systemic administration of LPS, which is sensed by TLR4, can
promote extramedullary hematopoiesis in the spleen (Esplin
et al., 2011; Vos et al., 1972). However, most preparations of
LPS are contaminated with peptidoglycan that activates NLRs
(Inohara et al., 2001). To determine whether TLRs and NLRs
play a role in driving the changes observed in HSC populations
during infection, we quantified LSK and CD150+ CD48 CD41
LSK cells in bone marrow and spleen of WT, Tlr4/, and
Ripk2/ mice before and after infection with E. coli (Figures
4A, 4B, and S5). We did not observe any differences in the total
number of CD150+ CD48 CD41 LSK cells in the bone marrow
or spleens of uninfected Tlr4/ orRipk2/mice compared with
uninfected WT mice (Figures 4A and 4B). Similar to WT mice, we
observed a reduction of total CD150+ CD48CD41 LSK cells in
bonemarrow ofRipk2/mice 3 days after infection, but this wasSystemic E. coli Infection
r spleens were isolated at indicated time points. Shown are representative flow
) total splenocytes, (E) total BM Lineage/low Sca1+ cKit+ (LSK), (F) total splenic
s. n = 3–8 mice per time point. Error bars indicate SEM. *p < 0.05 **p < 0.01 by
ost & Microbe 15, 779–791, June 11, 2014 ª2014 Elsevier Inc. 783
Figure 4. Combined Signaling of NOD-like
Receptors and Toll-like Receptors Is Impor-
tant for HSC Accumulation in Spleen during
Infection
(A and B) WT, Tlr4/, or Ripk2/ mice were in-
fected with 1 3 108 E. coli K12 i.p., and WBM or
splenocytes were isolated. Total HSCs (CD150+
CD48 CD41 LSK) were enumerated in (A) bone
marrow and (B) spleen. n = 3–8 mice per time
point. *p < 0.05 **p < 0.01 by two-way ANOVA
versus WT mice at same time point.
(C and D) WTmice were injected i.p. with PBS, the
TLR4 agonist LPS (100 ug), the NOD1 agonist
KF1B (50 ug), or both, and HSCswere quantified in
(C) bone marrow and (D) spleen at indicated time
points. n = 3–6 mice per time point. *p < 0.05, **p <
0.01 by two-way ANOVA versus PBS-treated
mice.
(E) WT, Ripk2/, or Trif/ mice were injected as
in (C) and (D), and HSCs were quantified in spleen
after 6 days. n = 3–6 mice per condition. **p < 0.01
by one-way ANOVA. See also Figure S5.
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LSK cells were increased in the spleen of Ripk2/mice by day 6
after infection, yet by day 9 after infection there were significantly
fewer CD150+ CD48 CD41 LSK cells in spleens of Ripk2/
mice compared with WT mice (Figure 4B). Strikingly, we
observed almost no accumulation of CD150+ CD48 CD41
LSK cells in spleens of Tlr4/mice at any point during infection
(Figure 4B). These results implicate NLR and TLR signaling in the
accumulation of extramedullary HSCs during infection.
NOD1 and TLR4Signaling Act Synergistically toMobilize
HSCs
To investigate whether activation of TLR and NLR signaling
pathways is sufficient to mobilize HSCs, we treated WT mice
with either ultrapure LPS, which is devoid of contaminating
peptidoglycan, or KF1B, a bacterial dipeptide that specifically
activates NOD1 (Masumoto et al., 2006), or both (Figures 4C
and 4D). A single i.p. injection of ultrapure LPS or KF1B alone
induced minimal alterations in the number of CD150+ CD48
CD41 LSK cells in bonemarrow or spleen over 6 days, whereas
dual administration of LPS and KF1B resulted in a reduction of
CD150+ CD48 CD41 LSK cells in bone marrow after 2 days
and an accumulation of CD150+ CD48 CD41 LSK cells in
spleen after 6 days (Figures 4C and 4D), reminiscent of changes
observed after E. coli infection. These results indicate that dual
activation of TLR4 and NOD1 cooperates to mobilize HSCs.
We challenged Ripk2/, Trif/, and Myd88/ mice with
PBS, LPS, KF1B, or both and quantified CD150+ CD48
CD41 LSK cells after 6 days (Figure 4E). Accumulation of
CD150+ CD48 CD41 LSK cells in the spleen after LPS and784 Cell Host & Microbe 15, 779–791, June 11, 2014 ª2014 Elsevier Inc.KF1B administration was dependent on
RIPK2 and TRIF (Figure 4E). Myd88/
mice had increased numbers of splenic
CD150+ CD48 CD41 LSK cells under
steady-state conditions, and no signifi-
cant differences were observed after
LPS and KF1B administration (data notshown). These results confirm that KF1B induces the activation
of NOD1,which signals through the adaptor RIPK2 in this setting,
and suggests that TLR4 signaling through TRIF is important for
inducing the mobilization of HSCs.
TLR4 Expression on HSCs Is Not Required for Their
Accumulation in Spleen
To test whether expression of TLR4 on HSCs influences their
reconstitution ability, we transplanted lethally irradiated WT
(CD45.1) mice with a mixture of 2.5 3 106 WT (CD45.1) WBM
and 2.5 3 106 Tlr4/ (CD45.2) WBM and measured peripheral
blood chimerism (Figures 5A and 5B). After 16 weeks, myeloid
reconstitution was equivalent between WT and Tlr4/ cells,
while B-lineage reconstitution was unbalanced in favor of
Tlr4/ cells and T-lineage reconstitution was unbalanced
in favor of WT cells (Figure 5B). These results indicate that
Tlr4/ HSCs are functionally comparable to WT HSCs, but
may harbor bias with respect to lymphoid reconstitution.
To determine whether TLR4 expression on HSCs themselves
was required for their accumulation in spleen, we challenged
the reconstituted mice with PBS or LPS and KF1B and
enumerated CD150+ CD48 CD41 LSK cells in spleen after
6 days (Figure 5C). We detected only minimal Tlr4/ CD150+
CD48 CD41 LSK cells in the spleens of PBS-treated mice,
whereas Tlr4/ CD150+ CD48 CD41 LSK cells were
increased in the spleens of LPS- and KF1B-treated mice (Fig-
ure 5C). To confirm these data functionally, we noncompetitively
transplanted 3 3 107 splenocytes from PBS or LPS and KF1B
treated mice into lethally irradiated CD45.1 recipients and
measured peripheral blood chimerism at 16 weeks (Figure 5D).
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majority of peripheral blood cells were WT derived, whereas in
recipients of LPS- and KF1B-treated splenocytes, Tlr4/ and
WT peripheral blood cells were roughly equivalent (Figure 5D).
These data indicate that expression of TLR4 on HSCs is not
required for their accumulation in spleen after TLR4 and NOD1
stimulation.
NLR and TLR Signaling in the Radio-Resistant
Compartment Is Important for Accumulation of Splenic
HSPCs
To determine which cellular compartment is required for medi-
ating TLR- and NLR-induced extramedullary hematopoiesis,
we generated reverse chimeras in which WBM from WT,
Ripk2/, or Tlr4/micewas transplanted into lethally irradiated
WT, Ripk2/, or Tlr4/ recipients. Chimeric mice were admin-
istered LPS and KF1B, and after 6 days splenocytes were plated
in Methocult 3434 medium to quantify myeloid and erythroid
progenitors. Ripk2/ recipients of Ripk2/ WBM and Tlr4/
recipients of Tlr4/ WBM exhibited blunted accumulation of
myeloid and erythroid progenitors in spleen, consistent with a
requirement for both TLR and NLR signaling in promoting
HSPCmobilization (Figures 5E and 5F). Accumulation of myeloid
and erythroid progenitors in the spleens ofWTmice that received
either Ripk2/ or Tlr4/WBMwas comparable to WT controls,
whereas Ripk2/ or Tlr4/ mice that received WT WBM
exhibited reduced accumulation of myeloid and erythroid pro-
genitors compared to WT controls (Figures 5E and 5F). These
results indicate that NLR and TLR signaling in radio-resistant
cells are required for mobilizing HSPCs and suggest that indirect
factors are involved.
G-CSF Signaling Is Required for NLR- and TLR-Induced
Mobilization of HSCs
Repeated administration of G-CSF induces the mobilization of
HSCs from bone marrow to peripheral blood and spleen in
both mouse and man (Du¨hrsen et al., 1988; Molineux et al.,
1990; Morrison et al., 1997), and systemic administration of
LPS can increase G-CSF in the serum (Hareng and Hartung,
2002), but a role for endogenous G-CSF in bacteria- or LPS-
induced mobilization has not been addressed. Compared with
naive mice, infection of WT mice with E. coli resulted in a 744-
fold increase of G-CSF in sera after 2 days (Figure 6A). Injection
of WT mice with ultrapure LPS resulted in 621-fold increase of
G-CSF in sera by 4 hr compared with 4-fold increase by KF1B
(Figure 6B). Moreover, the level of G-CSF in sera was synergisti-
cally enhanced to 1,627-fold by 4 hr with dual administration of
LPS and KF1B (Figure 6B). Treatment of Nod1/ mice with
LPS and KF1B resulted in G-CSF levels similar to WT mice
treated with LPS alone, confirming that KF1B acts exclusively
through NOD1 (Figure 6B).
To test whether G-CSF was required for HSC accumulation in
spleen, we injected WT mice with G-CSF blocking antibody or
isotype control 1 hr prior to injection with LPS and KF1B and
quantified CD150+ CD48 CD41 LSK cells in bone marrow
and spleen after 6 days (Figures 6C and 6D). Antibody pretreat-
ment did not influence the levels of CD150+ CD48 CD41 LSK
cells in the bone marrow, yet accumulation of CD150+ CD48
CD41 LSK cells in spleen was reduced in mice pre-treatedCell Hwith G-CSF blocking antibody but not isotype control antibody
(Figures 6C and 6D). We treated Csf3r/ (G-CSFR/) mice
with PBS or LPS and KF1B and found that the accumulation of
CD150+ CD48 CD41 LSK cells in spleens of these mice was
almost completely blocked (Figure 6D). These results indicate
that G-CSF signaling acts downstream of TLR4 and NOD1 to
promote the mobilization of HSCs.
CXCL12 is a chemokine critical for retention of HSCs in the
bone marrow niche and downregulation of CXCL12 in bone
marrow is a common feature of G-CSF-mediated mobilization
(Levesque andWinkler, 2008; Petit et al., 2002). CXCL12 expres-
sion was reduced 2-fold in WBM 2 days after E. coli infection
(Figure 6E). Single administration of LPS or KF1B did not signif-
icantly alter CXCL12 expression in WBM after 2 days, whereas
dual administration resulted in a 3-fold reduction of CXCL12
expression (Figure 6F). Thus, E. coli infection results in downre-
gulation of CXCL12 in bone marrow, and NOD1 and TLR4 can
act synergistically to mediate this phenomenon.
Endothelial cells are important producers of CXCL12 in the
bone marrow and contribute to the maintenance of HSCs under
steady-state conditions (Ding and Morrison, 2013; Ding et al.,
2012; Greenbaum et al., 2013). To test whether endothelial cells
could respond to bacterial components, we cultured the mouse
endothelial cell line C166 in the presence of LPS, KF1B, or super-
natants from E. coli grown in vitro (Figure 6G and H). KF1B alone
did not induce G-CSF production in C166 cells, while LPS alone
increased G-CSF production by 39-fold, and coadministration
synergistically enhanced G-CSF production by 167-fold (Fig-
ure 6G). E. coli supernatants were also sufficient to increase
G-CSF production by 115-fold (Figure 6G). LPS or KF1B treat-
ment alone reduced CXCL12 expression by 1.6- and 1.5-fold,
respectively, whereas coadministration reduced CXCL12
expression by 3-fold (Figure 6H). Culture with E. coli superna-
tants resulted in 1.5-fold reduction of CXCL12 expression (Fig-
ure 6H). These results suggest that endothelial cells may be
important for sensing bacterial components through NOD1 and
TLR4 and promoting mobilization during infection.
NOD1 and TLR4 Mobilized HSPCs Give Rise to
Neutrophils and Monocytes and Contribute to Limiting
Infection
Finally, we wished to determine whether PRR-mediated mobili-
zation of HSPCs influenced subsequent bacterial infection. To
address the contribution of mobilized splenic HSPCs and their
progeny to infection, we devised the experiment described in
Figure 7A. Wild-type (CD45.1) mice were pretreated with isotype
control or aG-CSF antibody to permit or block mobilization,
respectively, followed by injection of PBS or LPS and KF1B. After
6 days, 4 3 107 unfractionated splenocytes were transplanted
into sublethally irradiated WT (CD45.2) mice. Seven or eight
days later, recipient mice were infected i.p. with 1 3 107 CFU
of E. coli and sacrificed after 2 days to measure bacterial CFUs
and cell chimerism. Mice that received splenocytes from mobi-
lized mice (group 3) were more efficient at reducing the systemic
load of E. coli compared with mice receiving un-mobilized sple-
nocytes (group 1) and mice receiving splenocytes where mobili-
zation was blocked (group 4) (Figure 7B). Donor splenocytes
containing mobilized HSPCs contributed robustly to Ly6Ghi
Mac1+ neutrophils and CD115+ Mac1+ monocytes in the bloodost & Microbe 15, 779–791, June 11, 2014 ª2014 Elsevier Inc. 785
Figure 5. Radio-Resistant Cells Are Important for NOD1- and TLR4-Induced HSC Accumulation in Spleen
(A) Schematic of experiments in (B)–(D).
(B) Peripheral blood chimerismmice transplanted with a 1:1 mixture of WT and Tlr4/WBM and bled every 4 weeks. n = 7 mice, **p < 0.01, by two-way ANOVA.
(C) After 16 weeks, chimeric mice were injected with PBS or LPS + KF1B, and 6 days later the absolute number of HSCs (CD150+ CD48 CD41 LSK) in spleen
was enumerated. n = 3–4 mice per condition. *p < 0.05 by one-way ANOVA.
(legend continued on next page)
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Figure 6. NOD1- and TLR4-Induced HSC
Accumulation in Spleen Is Dependent on
G-CSF
(A) G-CSF in sera after i.p. injection of WT mice
with 1 3 108 E. coli. n = 3–7 mice per time point.
(B) G-CSF in sera 4 hr after i.p. injection of WT or
Nod1/ mice with KF1B (50 ug), LPS (100 ug), or
both. Each data point represents one mouse.
(C and D) Quantification of HSCs (CD150+ CD48
CD41 LSK) in (C) bone marrow or (D) spleen
6 days after challenge. Where indicated, WT mice
received 250 ug of isotype control or G-CSF-
blocking antibody (Ab) i.p. 1 hr before challenge.
n = 3–5 mice per condition.
(E) CXCL12 expression in WBM following infection
of WT mice as in (A).
(F) CXCL12 expression in WBM 2 days after in-
jection of WT mice as in B. n = 3–5 mice per
condition.
(G) G-CSF in supernatants from cultured C166
endothelial cells 24 hr after stimulation with KF1B
(1 ug/mL), LPS (10 ng/mL), both, or E. coli super-
natant (Sup).
(H) CXCL12 expression in cultured C166 endo-
thelial cells 4 hr after stimulation as in (G). Data are
representative of at least three independent
experiments. *p < 0.05, **p < 0.01, by one-way
ANOVA for all graphs. (ns), not significant. Error
bars represent SEM.
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Infection Mobilizes HSCs to Spleen via PRR Signalingand peritoneum compared with recipients of other groups (Fig-
ures 7C and 7D), which correlated with reduced systemic bacte-
rial load in these mice. Together, these data indicate that splenic
HSPCs, mobilized by dual NLR and TLR signaling, give rise to(D) 3 3 107 splenocytes from mice in (B)–(C) were transplanted noncompetitively into lethally irradiated rec
16 weeks after transplant.
(E and F) Chimeras were generated as described in text. Mice were injectedwith PBS or LPS +KF1B, and after
n = 3–7 mice per condition. *p < 0.05 by one-way ANOVA. Error bars represent SEM. Burst forming unit
(erythroid); –G (granulocyte); –M (macrophage); –GM (granulocyte-macrophage).
Cell Host & Microbe 15, 779–7enhanced numbers myeloid cells and
contribute to the fight against infection.
DISCUSSION
A growing body of evidence has emerged
supporting a role for hematopoietic
progenitors, including long-term multili-
neage repopulating HSCs, in the fight
against infection, yet mechanisms gov-
erning the response of HSCs to infection
are poorly understood. Here we have
demonstrated that systemic infection
with the Gram-negative bacterium
E. coli drives the mobilization and accu-
mulation of long-term multilineage repo-
pulating HSCs in the spleen along with a
moderate reduction of HSCs in the bone
marrow.Moreover, we find that activation
of both Toll-like receptors and NOD-likereceptors are important for the accumulation of splenic HSCs
after E. coli infection. Together, our results illustrate that detec-
tion of bacterial components via PRRs is a crucial step in the initi-
ation of extramedullary hematopoiesis following infection.ipients and peripheral blood chimerism measured
6 days splenocytes were plated inMethocult 3434.
(BFU) –E (erythroid); colony-forming unit (CFU) –E
91, June 11, 2014 ª2014 Elsevier Inc. 787
Figure 7. NOD1 and TLR4 Mobilized HSPCs Contribute to Limiting Infection
(A) Schematic of experiments in (B)–(D).
(B) Colony-forming units (CFUs) of E. coli NI491 per gram of spleen or liver 2 days after infection. Each data point represents CFUs from one mouse.
(C) Peripheral blood chimerism 1 day before and 2 days after infection. Neutrophils were defined as Ly6Ghi Mac1+, and monocytes were defined as CD115+
Mac1+.
(D) Total cell numbers and chimerism from peritoneal cavity 2 days after infection. Black bars represent donor splenocyte derived cells, while gray bars represent
residual recipient-derived cells. n = 5–6 mice per group combined from two independent experiments. *p < 0.05, **p < 0.01, by one-way ANOVA for all graphs.
Error bars represent SEM.
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Cell Host & Microbe
Infection Mobilizes HSCs to Spleen via PRR SignalingSystemic administration of LPS results in the mobilization of
HSPCs (Vos et al., 1972), but the cell types and signaling path-
ways responsible for this phenomenon are unclear. We found
that the accumulation of splenic HSCs following infection was
largely dependent on TLR4 signaling and partially dependent
on NLR signaling via the adaptor protein RIPK2. Importantly,
administration of ultrapure LPS alonewas not sufficient to induce
the accumulation of HSCs in the spleen, whereas dual adminis-
tration of LPS and the synthetic NOD1 agonist KF1B was suffi-
cient. Thus, our studies highlight a previously unappreciated
role for NLR signaling in promoting extramedullary hematopoie-
sis in the context of infection and suggest that contamination of
LPS preparations with NLR-activating peptidoglycan moieties
likely contributed to the mobilization of HSPCs observed previ-
ously. Interestingly, whereas a recent report found that multipo-
tent progenitors are capable of directly responding to TLR
ligands and producing cytokines to coordinate inflammatory
responses (Zhao et al., 2014), our data point toward radio-resis-
tant cells such as endothelial cells as initiators of themobilization
response following infection. In support of this concept, HSCs
did not require the expression of TLR4 on their surface to accu-
mulate in spleen following PRR activation. In fact, more Tlr4/
HSCs accumulated in spleen compared with WT HSCs. The
reason for this is unclear, but one possibility is that Tlr4/
HSCs may have weaker associations with bone marrow niches
and might be preferentially mobilized when directly competing
with WT HSCs.
It was originally unclear whether the accumulation of splenic
HSCs that occurs following infection was due to expansion of
resident HSCs or mobilization of HSCs from the bone marrow.
In support of mobilization, we found that less than 5% of splenic
HSCs were actively cycling at a time when their numbers were
rapidly increasing. Moreover, we found that dual activation
of TLR4 and NOD1 resulted in the synergistic production of
G-CSF in the serum, which correlated with accumulation of
HSCs in the spleen. Inhibition of G-CSF signaling either by a
G-CSF blocking antibody or lack of the G-CSF receptor was
sufficient to limit HSC accumulation in the spleen, indicating
that G-CSF plays a crucial role downstream of PRR activation
to promote HSC mobilization during infection.
The spleen serves as a site for extramedullary hematopoiesis
during periods of stress, yet the spleen is not essential for life.
The biological significance for an expanded pool of splenic
HSCs during infection is not clear. We found that HSPCs which
had been mobilized to the spleen by PRR stimulation preferen-
tially gave rise to neutrophils and monocytes and reduced the
systemic bacterial burden following transplantation and infection
with E. coli. Given the immense need for cell replenishment
during systemic infection, it is likely that mobilization of HSPCs
to the spleen provides an additional site for generation of effector
cells during infection. This is supported by evidence that the
spleen serves as a reservoir for monocytes that contribute to
the resolution of sterile inflammation (Swirski et al., 2009).
Another nonexclusive possibility is that excessive inflamma-
tory signaling within the bone marrow microenvironment might
transiently compromise the stem cell niche. We and others
have found that CXCL12 is downregulated in bone marrow after
exposure to bacteria or their components, and this was associ-
ated with bone marrow hypocellularity (Delano et al., 2011;Cell HJohns and Borjesson, 2012; Ueda et al., 2005). Interestingly,
CXCL12 also contributes to the retention of neutrophils in bone
marrow, and mobilization of neutrophils during polymicrobial
sepsis is required for bacterial clearance and host survival
(Delano et al., 2011). Moreover, physiologic trafficking of HSPCs
between the bone marrow and blood stream is influenced by the
level of circulating neutrophils, and removal of aged neutrophils
by bone marrow macrophages promotes HSPC mobilization
(Casanova-Acebes et al., 2013). Egress of HSCs could merely
represent a bystander effect secondary to an immediate require-
ment for peripheral granulocytes, or it could serve as a protective
mechanism to maintain these cells until the infection is cleared
and the bone marrow niche is repaired. Surprisingly, we did
not observe any accumulation of CD150+ CD48 LSK cells in
the liver or inguinal lymph nodes of E. coli infected mice, sug-
gesting that the spleen may serve as a specialized niche to sup-
port HSC function during systemic infection.
The mobilization of HSCs during bacterial infection highlights
the dynamic nature of stem cells and their niche(s) in the setting
of stress. Our results support the hypothesis that the initiation of
extramedullary hematopoiesis during infection is a consequence
of alterations in the HSC microenvironment initiated by recogni-
tion of bacterial components via host PRRs. A better under-
standing of the signals that influence HSCs and their niche(s)
during infection may lead to improved methodologies for isola-
tion and expansion of HSCs in the clinical setting.
EXPERIMENTAL PROCEDURES
Mice
CD45.2 (C57BL/6) and CD45.1 (B6.SJL-Ptprca Pepcb/BoyJ) mice were pur-
chased from Jackson Laboratories. Nod1/ mice were kindly provided by
Grace Chen (University of Michigan). Csf3r/ (G-CSFR/) mice were kindly
provided by Daniel Link (Washington University, USA). Myd88/, Trif/,
and Tlr4/ were kindly provided by Shizuo Akira (Osaka University, Japan).
All mice were maintained under SPF conditions at the University of Michigan.
All experiments were approved by the University of Michigan Committee on
the Care and Use of Animals.
Reagents
KF1B has been reported (Masumoto et al., 2006). E. coli K12 was obtained
from ATCC (ATCC 19798). E. coli NI491 was isolated from the intestine of a
C57BL/6 mouse and the bacterial species verified by 16S rRNA sequencing.
Ultrapure LPS (E. coli K12) was purchased from Invivogen. Antibodies target-
ing G-CSF (clone 67604) and rat IgG1 isotype control were a gift from CSL
Limited, Australia, and used as described previously (Lawlor et al., 2004).
Bacterial Culture and Infection
E. coli K12 or NI491 was picked from frozen glycerol stock into LB broth,
shaken at 37C overnight, and subcultured in LB for another 2–3 hr. Bacteria
were washed multiple times in PBS and numbers were estimated by optical
density at 600 nm. Mice were injected i.p. with bacteria diluted in PBS, and
residual bacteria was serially diluted in PBS and plated on LB agar to quanti-
tate CFU.
Cell Isolation and Flow Cytometry
Bonemarrow cells were isolated by flushing one femur and tibia with 3 ml Ca2+
and Mg2+ free HBSS supplemented with 2% HI FBS, filtered through a 50 mm
mesh, and counted using a hemocytometer. Splenocytes were obtained by
mashing between two glass slides and filtered through a 100 mm mesh. Line-
age cocktail was comprised of biotin-labeled lineage panel (CD3e 145-2C11,
B220 RA3-6B2, TER119, Gr-1 RB6-8C5, Mac1M1/70 eBioscience) along with
biotin CD4 (GK1.5 BioLegend) andCD8a (53-6.7 BioLegend) followed by stain-
ing with Streptavidin Pacific Orange (Invitrogen). Antibodies used to stainost & Microbe 15, 779–791, June 11, 2014 ª2014 Elsevier Inc. 789
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(HM48-1 BioLegend), PE Cy7 CD41 (MWReg eBiosciences), APC Sca1
(E13-161.7 BioLegend), and APC Cy7 cKit (2B8 BioLegend). Antibodies
used to stain peripheral blood included FITC CD45.2 (104 BioLegend), PE
CD3e (145-2C11 BioLegend), PE CD115 (AFS98 BioLegend), PE Cy5 B220
(RA3-6B2 eBioscience), PE Cy7 Gr-1 (RB6-8C5 BioLegend), PE Cy7 Ly6G
(1A8 BD PharMingen), APC Mac1 (M1/70 eBioscience), APC Cy7 CD45.1
(A20 eBioscience), biotin CD3e (145-2C11, eBioscience), biotin CD4 (GK1.5
BioLegend), and biotin CD8a (53-6.7 BioLegend).
Long-Term Reconstitution Assays
Ten-week-old or older recipient mice were lethally irradiated using X-ray
(Phillips RT250, Kimtron Medical) with two doses of 540 rad (total 1,080) deliv-
ered between 3 and 24 hr apart. In some experiments, 33 105WBMor 13 106
splenocytes were mixed with 3 3 105 competitor WBM and transplanted via
tail vein injection. To determine the surface marker profile of HSCs after infec-
tion, WBM or spleen was harvested from mice after 6 days, purity sorted to
enrich for the positive or negative fraction, purity sorted again, and mixed
with 3 3 105 WBM prior to retro-orbital injection. Recipient mice were main-
tained on antibiotic water (neomycin sulfate 1.11 g/L and polymyxin B sulfate
0.121 g/L, 50 g/L sucrose) for at least 6 weeks. In experiments where live
E. coli-exposed cells were transplanted, recipient mice received 5 mg/kg
enrofloxacin (Bayer) i.v. at day 0 and s.c. at day 5 posttransplant. To generate
reverse chimeras, 53 106WBM fromWT, Tlr4/, orRipk2/mice was trans-
planted via tail vein into lethally irradiated WT, Tlr4/, or Ripk2/ mice, and
recipients were allowed to recover for 16 weeks prior to challenge. For suble-
thal irradiation, recipient mice received a single dose of 800 rad.
C166 Endothelial Cell Culture
C166 yolk sac endothelial cells (ATCC CRL-2581) were cultured in DMEM
supplemented with 10% FBS and pen/strep. Ultrapure LPS (Invivogen;
E. coli 011:B4) was added to media at final concentration of 10 ng/mL, while
KF1B was added at a final concentration of 1 ug/mL. For stimulation with
bacterial supernatants, E. coli K12 was shaken overnight at 37C in LB media,
centrifuged, and passed through 0.2 um filter.
Quantitative PCR
Cells were homogenized using a column (Omega), and RNAwas isolated using
a Total RNA kit (Omega). Eluted RNA was reverse transcribed into cDNA using
High-Capacity RNA-to-cDNA kit (Applied Biosystems). Quantitative real-time
PCR was performed using SYBR Green (Applied Biosystems). Gene expres-
sion was normalized to the housekeeping gene GAPDH. Primers for CXCL12
were F- TGCATCAGTGACGGTAAACCA and R- GTTGTTCTTCAGCCGTG
CAA and for GAPDH were F- TGCGACTTCAACAGCAACTC and R- GCCT
CTCTTGCTCAGTGTCC.
Methylcellulose Culture
Splenocytes were counted using a hemocytometer, diluted in Methocult
M3434 medium (Stem Cell Technologies) and incubated at 37C for 8–
12 days, after which myeloerythroid colonies were quantified.
Statistical Analysis
All statistics were performed using Graphpad Prism software. Statistical tests
used are described in the figure legends.
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